“Pharmacotherapeutic follow-up to patients with Parkinson’s disease using the drugs Levodopa and Biperiden hydrochloride: Interactions in drug treatment” (2022) Research, Society and Development, 11(15), p. e65111536721. doi:10.33448/rsd-v11i15.36721.